Robert Rosenson
University of Alabama at Birmingham
7 Papers
773 Citations
Robert Rosenson is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Stroke & Framingham Risk Score. The author has an hindex of 3, co-authored 7 publications.
Chat about Author
Papers
ACCF/AHA Expert Consensus Document ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
Wilbert S. Aronow,Jerome L. Fleg,Carl J. Pepine,Nancy T. Artinian,George Bakris,Alan S. Brown,Keith C. Ferdinand,Mary Ann Forciea,William H. Frishman,Cheryl Jaigobin,John B. Kostis,Giuseppi Mancia,Suzanne Oparil,Eduardo Ortiz,Efrain Reisin,Michael W. Rich,Douglas D. Schocken,Michael A. Weber,Deborah J. Wesley,Robert A. Harrington,Eric R. Bates,Deepak L. Bhatt,Charles R. Bridges,Mark J. Eisenberg,Victor A. Ferrari,John D. Fisher,Timothy J. Gardner,Federico Gentile,Michael F. Gilson,Mark A. Hlatky,Alice K. Jacobs,Sanjay Kaul,David J. Moliterno,Debabrata Mukherjee,Robert Rosenson,James H. Stein,Howard H. Weitz +36 more
- 01 Jan 2011
TL;DR: The reader should view the expert consensus document as the best attempt of the ACCF and document cosponsors to inform and guide clinical practice in areas where rigorous evidence may not yet be available or evidence to date is not widely applied to clinical practice.
766
Efficacy and safety of the pcsk9 inhibitor evolocumab in patients with mixed hyperlipidemia
Robert Rosenson,Terry A. Jacobson,D. Priess,C. Djedjos,Ricardo Dent,Ian Bridges,A. Pellacani,Michael Miller +7 more
TL;DR: The significant reductions of atherogenic lipids including LDL-C, non-high-density lipoprotein (HDL-C) and apolipoprotein B seen with evolocumab are similar in patients with and without mixed hyperlipidemia.
23
Low high-density lipoprotein cholesterol and incident coronary heart disease among blacks in the reasons for geographic and racial differences in stroke (regards) study
Lisandro D. Colantonio,Michael Miller,Maciej Banach,Robert Rosenson,Monika M. Safford,Sergio Fazio,Paul Muntner,Peter P. Toth +7 more
TL;DR: This work examined the association of low HDL-C with incident CHD among whites with low levels of low-density cholesterol in the context of coronary heart disease.
3
Prevalence and correlates of statin side effects and willingness to be re-challenged on a statin: data from the reasons for geographic and racial differences in stroke (regards) study
Rikki M. Tanner,Lisandro D. Colantonio,Monika M. Safford,Keri Monda,Ben Taylor,Paul Muntner,Robert Rosenson +6 more
TL;DR: The prevalence and correlates of side effects experienced among REGARDS study participants who completed a statin use survey determined that individuals who discontinue statins due to side effects can be successfully re-challenged.
2
Document of the American College of Cardiology Foundation Statement of the American Heart Association, and an Expert Consensus Scientific Diabetes: A Position Statement of the American Diabetes Association, a Aspirin for Primary Prevention of Cardiovascular Events in People With
M. Sue Kirkman,Debabrata Mukherjee,Robert Rosenson,Craig D. Williams,Mark J. Alberts,John A. Colwell,Mary Cushman,E Silvio +7 more
- 01 Jan 2010
1